A fair comment and actually one of your best.
The problem has always been this company was sold to investors as one of the more safests of biotech "bets".. (as in risks to take)...
What do I mean by that?
Backed by ex FMG boys...(one would expect sound business nouse wouldn't you agree?)
Boring primary product (beef cows) being made into patches in Australia (free of proteon's and disease risk).. ie great pricing power and financial "moat" to product undercut pricing?
Sold infusions business already making a profit providing steady cash flow to fund more risky operations..
Well at least that's how I used to view it..
So what went so wrong?
Have you ever actually asked yourself that? (and worked out the answer)?
IMO.
AGM Video, page-19
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.49 |
Change
0.490(4.08%) |
Mkt cap ! $264.0M | |||
| Open | High | Low | Value | Volume |
| $12.11 | $12.49 | $11.50 | $155.8K | 13.16K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 175 | $11.81 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.49 | 77 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |